The Valley Desk

ArticleLeukemiaPublished

Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response

24 of 38 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
Leukemia
Published
Subject terms
Cell Line, Tumor; Mitochondria; Animals; Humans; Mice; Reactive Oxygen Species; Mevalonic Acid; Polyisoprenyl Phosphates; Cytarabine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Drug Resistance, Neoplasm; Mutation
PubMed ID
40634510
PubMed Central ID
PMC12380605
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal